Navigation Links
Exforge Helps Vast Majority of Patients Effectively Control Their,Blood Pressure After Failing on Other Medicines, According to New,Clinical Data

  • Nine out of 10 non-diabetic patients treated with Exforge achieved recommended blood pressure goals[1]
  • Additional average decrease of 20 mmHg in systolic blood pressure observed in patients taking Exforge over reductions seen with previous monotherapy[1]
  • Nearly 70% of those with high blood pressure not at treatment target levels[2] and most require two or more medications to achieve goal[2]
BASEL, Switzerland, May 21, 2007 - Exforge®, a single-tablet combination of two of the world's most commonly prescribed high blood pressure medicines[3],[4], has been shown in new clinical data to have helped nine out of 10 non-diabetic patients to reach their treatment goals after having previously failed to do so with single medicines[1].
The results showed patients taking Exforge experienced on average an additional 20 mmHg drop in systolic blood pressure compared to reductions seen with their previous medication[1]. The data from this trial involving 894 patients were presented today at the Annual Scientific Meeting of the American Society of Hypertension (ASH) in Chicago.
The efficacy of Exforge, which combines the angiotensin receptor blocker (ARB) valsartan (Diovan®) and the calcium channel blocker (CCB) amlodipine in one tablet, was again demonstrated in this trial, even in patients considered to be more difficult to treat such as the elderly or those with type 2 diabetes[1]. Exforge was well-tolerated at the doses used in this trial[1].
The study - designed to assess the use of Exforge in a real-life treatment environment - showed that patients who had failed to reach the recommended blood pressure goal of 140/90 mmHg (systolic/diastolic pressure) on a range of si
'"/>




Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ApoCells Cancer Predictive Index Helps Oncologists Select the Most Effective Targeted Drug Therapy
2. Study Suggests Invega Helps Patients With Schizophrenia Maintain Symptom Control
3. International ENDORSE Study Shows That the Majority of Hospitalized Patients Surveyed are at Risk for VTE and Many do not Receive Recommended VTE prophylaxis
4. Hematology Analyzers Simple, Sophisticated Technology Serving All Patients
5. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
6. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
7. New Study Shows That Extending Prophylaxis With Clexane / Lovenox (enoxaparin Sodium Injection) to 5 Weeks is More Effective Than 10 Days for Reducing the Risk of Venous Thromboembolism (VTE) in Acutely ill Medical Patients With Reduced Mobility
8. Phase III Trial Results Show Superiority of Rivaroxaban over Enoxaparin for the Prevention of Venous Thromboembolism in Patients Undergoing Knee Replacement Surgery
9. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea
10. TMC125 Showed Significant Virologic Response at Week 24 in Treatment-Experienced HIV Patients With NNRTI Resistance in Phase 3 Trials
11. Study Shows Ixabepilone Demonstrated Clear Activity in Patients with Metastatic Breast Cancer Resistant to Anthracycline, Taxane, and Capecitabine
Post Your Comments:
(Date:5/29/2015)... DIEGO and BOSTON , ... leader in instrument development, custom automation, and contract manufacturing, ... of the Nanopatch™ needle-free drug delivery technology, have been ... development of the Nanopatch Jet Coating Instrument , ... delivery research and product development.  The award was announced ...
(Date:5/29/2015)... , May 29, 2015 /CNW/ - Covalon Technologies Ltd. ... medical technologies company, is delighted to announce its ... 31, 2015, which includes revenue for three months ... of $264,340. Revenue from advanced wound care product sales ... 2015 increased 24% to $1,742,672 compared to $1,400,065 ...
(Date:5/29/2015)... British Columbia and MENLO ... -- DelMar Pharmaceuticals, Inc. (OTCQX: DMPI) ... on developing and commercializing proven cancer therapies in ... at the American Association of Cancer Research ... on the potential for its lead product candidate ...
Breaking Medicine Technology:Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 2Invetech And Vaxxas Named Recipients Of The 2015 Good Design Award For Development Of Nanopatch Jet Coating Instrument For Needle-Free Drug Delivery 3Covalon Announces Strong Second Quarter Results 2Covalon Announces Strong Second Quarter Results 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 2DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 3DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 4DelMar Pharmaceuticals Presents Additional Data on the Potential of VAL-083 in the Treatment of Temozolomide-Resistant Glioblastoma Multiforme 5
... ALEXANDRIA, Va., April 16, 2012 Thirty years ... was passed, enabling tens of millions of Americans ... at life,s end from the nation,s dedicated hospice ... the most compassionate corps of trained volunteers seen ...
... PITTSBURGH, April 16, 2012  Mastech Holdings, Inc. (NYSE ... provider of Information Technology and Specialized Healthcare Staffing services, has scheduled ... first quarter ended March 31, 2012.  The conference ... at 9:00 a.m. Eastern Time and will be ...
Cached Medicine Technology:Thirty Years Since Medicare Hospice Legislation Recognized Value of Hospice Volunteers 2Mastech Holdings, Inc. to Discuss First Quarter 2012 Financial Results on April 25, 2012 2
(Date:5/29/2015)... 2015 Ready to hit the road? Before ... drivers to get their vehicles ready. With handicapped vehicles, there ... Driving Systems (ADS) is ready to help drivers get their ... summer road trips. , When planning for the big trip, ... that the trip goes smoothly and they are prepared for ...
(Date:5/29/2015)... Island (PRWEB) May 29, 2015 The ... 2015. The event, now closed to new registration, starts ... Adams. This exciting competitive running event demonstrates the ... to create a public benefit – in this case, ... coastal views around the famed Ocean Drive and passes ...
(Date:5/29/2015)... CA (PRWEB) May 29, 2015 The science ... in the last decade. New and more efficient methods of ... available to balding patients. One of the most cutting edge ... Mohebi Hair Restoration is the technique of extracting hair from ... scalp transplants are performed to correct male pattern baldness. ...
(Date:5/29/2015)... 2015 Red Hot & Blue Restaurants ... Hot & Blue restaurant at 525 New Waverly Place in ... 2015. “The Red Hot & Blue Restaurant was previously located ... we have moved to a new location in the center,” ... of all the activities on the Promenade–with outdoor seating and ...
(Date:5/29/2015)... (PRWEB) May 29, 2015 The ... the graduates of its Advanced Training Program (ATP) ... who fill roles in their health care organization ... theory and methodology of continuous quality improvement in ... sister-program to Dr. Brent James’ internationally recognized Advanced ...
Breaking Medicine News(10 mins):Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 2Health News:Advanced Driving Systems Offers Tips for Summer Road Trips 3Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 2Health News:The Newport 10 Miler at Fort Adams, an Outstanding Example of Event Marketing Helping in Preservation, is Now Completely Booked for 2015 3Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 2Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 3Health News:Red Hot & Blue Restaurant Opens in Cary, North Carolina 4Health News:HORNE LLP’s Healthcare Delivery Institute Graduates Class from the Advanced Training Program 2
... Health Market Science,(HMS) has been named to Deloitte,s ... ranking of the 50 fastest growing technology,media, telecommunications ... & Touche USA LLP, one of the nation,s ... percentage revenue growth,over five years from 2002-2006. The ...
... Jack Group, Inc.,(MattsonJack) announces the release of its ... help clients make strategic,decisions based on an in-depth ... conditions. Comorbidity Database(TM) consists of,two modules: Comorbidity Database(TM) ... and Comorbidity Database(TM) -- Med 2.0, which features ...
... the Board of Governors Gene Therapeutics Research Institute at ... that it is possible to sustain therapeutic gene expression ... year, even in the presence of an anti-viral immune ... , The researchers demonstrated in an animal model that ...
... Therapeutics Inc.,("Transition") (NASDAQ: TTHI , TSX: TTH) ... half of the US$15 million upfront payment,under the ... Corporation, plc ("Elan") (NYSE: ELN ) for ... completed Phase I clinical trials and the drug,candidate ...
... One of the nation,s largest and most respected radiology ... with AMICAS to revolutionize radiology IT solutions, ... AMCS ),a leader in radiology and medical image and ... new enterprise agreement,with Radiology Ltd. of Tucson, AZ. ...
... 26 People with,diabetes who have asymptomatic heart disease ... to their hearts without surgical intervention, according,to a study ... which,comes out on October 26, 2007., Researchers found ... aggressively treated their cardiac risk factors with,medication were able ...
Cached Medicine News:Health News:Health Market Science Ranked Number Ten in Deloitte's Technology Fast 50 Program for Greater Philadelphia 2Health News:Health Market Science Ranked Number Ten in Deloitte's Technology Fast 50 Program for Greater Philadelphia 3Health News:The Mattson Jack Group, Inc. Announces the Release of the New Comorbidity Database(TM) 2Health News:Transition Therapeutics Receives Remaining Upfront Payment from Elan Corporation, plc 2Health News:Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider 2Health News:Radiology Ltd. Chooses AMICAS as End-to-End Solutions Provider 3Health News:Aggressively Treating Cardiac Risk Factors May Reverse Ischemia 2
... are automated, easy to operate and maintain. ... environment by flexible snap-seal pockets which minimize ... contamination of the water. Offered in two-, ... also accommodate bags of various sizes. ThermoLine ...
... thawing systems are automated, easy to operate ... the outside environment by flexible snap-seal pockets ... or viral contamination of the water. Offered ... systems can also accommodate bags of various ...
Conventional Digitally-Controlled Water Baths...
Dry thaws. Has an ingenious (pat. pending) massaging sytem that utilizes the tempered bladders as hands. There are no unreliable mechanical parts involved. Two pumps pressurize different segments of ...
Medicine Products: